Men who are not eligible for routine prostate-specific antigen (PSA) blood tests on the NHS are paying out of pocket for private testing to help check for prostate cancer.
Some private healthcare companies have been offering promotional discount in the wake of a recommendation that screening should only be offered to men with a BRCA2 gene variant and a family history of certain cancer types.
But health leaders have warned that PSA testing, which is designed to detect levels of a protein produced by the prostate gland, can do more harm than good for many, due to inaccurate results and unnecessary testing and treatment.
Shorts
For Adrian Lydiard, 60, from Solihull, opting for a private PSA test was a no-brainer, after several family members were diagnosed with the disease
